Suven Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 06/11/2021 to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the second quarter and half-year ending September 30, 2021 and related matters. Trading Window for dealing in the securities of the company is already closed from 01st October, 2021 as per PIT Code of the Company. Trading window will be opened from 10th November, 2021.
The above information is a part of company’s filings submitted to BSE.
